Samuel Oommen

John Muir Health — United States

Medicine · Health Sciences

9h-index2.8kcitations11works55.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Surgical Treatments(11), Colorectal and Anal Carcinomas(9), Colorectal Cancer Screening and Detection(6), Gastric Cancer Management and Outcomes(2), Radiomics and Machine Learning in Medical Imaging(2)

Publications11 total

MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer
Radiology·2024· 14 citedOpen Access
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy
JAMA Network Open·2024· 97 citedOpen Access
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial
Journal of Clinical Oncology·2023· 266 citedOpen Access
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Journal of Clinical Oncology·2022· 826 citedOpen Access
Does Adherence to National Accreditation Program for Rectal Cancer (NAPRC) Process Measures Lead to Better Outcomes in the Management of Rectal Cancer? Initial Experience From the First NAPRC Accredited Center in the Country
Journal of the American College of Surgeons·2021· 5 cited
Survival and organ preservation according to clinical response after total neoadjuvant therapy in locally advanced rectal cancer patients: A secondary analysis from the organ preservation in rectal adenocarcinoma (OPRA) trial.
Journal of Clinical Oncology·2021· 34 cited
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial
Diseases of the Colon & Rectum·2018· 162 citedOpen Access
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
The Lancet Oncology·2015· 413 citedOpen Access
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
The Lancet Oncology·2015· 681 citedOpen Access
A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial
Annals of Surgical Oncology·2011· 299 citedOpen Access
Laparoscopic proctectomy after neoadjuvant therapy: safety and long-term follow-up
Surgical Endoscopy·2010· 6 cited

Frequent Co-authors

Julio García‐Aguilar(9), Jorge Marcet(9), Peter A. Cataldo(9), Daniel O. Herzig(8), Blasé N. Polite(7), Charles A. Ternent(7), Steven R. Hunt(7), Sujata Patil(5), Marc J. Gollub(5), Jonathan B. Yuval(5), David Liska(5), Charles M. Friel(5), Andrew L. Coveler(5), Madhulika G. Varma(5), Abraham J. Wu(5), Jin K. Kim(4), Hannah M. Thompson(4), Floris S. Verheij(4), Dana M. Omer(4), Meghan Lee(4)